Reply to: "Endothelial progenitor cell release is usually considered a beneficial effect: Problems in interpreting the acute effects of e-cigarette use"

Affiliations

¹ Karolinska Institutet, Department of Clinical Sciences, Division of Internal Medicine, Danderyd University Hospital, Stockholm, Sweden. Electronic address: lukasz.antoniewicz@ki.se.
² Karolinska Institutet, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd University Hospital, Stockholm, Sweden.
³ Karolinska Institutet, Department of Medicine, Solna, Stockholm, Sweden.

Comment

Lukasz Antoniewicz et al. Atherosclerosis. 2017 Mar.

. 2017 Mar:258:164-165.

doi: 10.1016/j.atherosclerosis.2017.01.019. Epub 2017 Jan 21.

¹ Karolinska Institutet, Department of Clinical Sciences, Division of Internal Medicine, Danderyd University Hospital, Stockholm, Sweden. Electronic address: lukasz.antoniewicz@ki.se.
² Karolinska Institutet, Department of Clinical Sciences, Division of Cardiovascular Medicine, Danderyd University Hospital, Stockholm, Sweden.
³ Karolinska Institutet, Department of Medicine, Solna, Stockholm, Sweden.

No abstract available

Comment on

Electronic cigarettes increase endothelial progenitor cells in the blood of healthy volunteers.
Antoniewicz L, Bosson JA, Kuhl J, Abdel-Halim SM, Kiessling A, Mobarrez F, Lundbäck M. Antoniewicz L, et al. Atherosclerosis. 2016 Dec;255:179-185. doi: 10.1016/j.atherosclerosis.2016.09.064. Epub 2016 Sep 22. Atherosclerosis. 2016. PMID: 27693003 Clinical Trial.
Endothelial progenitor cell release is usually considered a beneficial effect: Problems in interpreting the acute effects of e-cigarette use.
Farsalinos KE, Polosa R. Farsalinos KE, et al. Atherosclerosis. 2017 Mar;258:162-163. doi: 10.1016/j.atherosclerosis.2016.12.016. Epub 2016 Dec 21. Atherosclerosis. 2017. PMID: 28034508 No abstract available.